Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Sarepta Therapeutics Inc.
DescriptionSingle oligomer nucleic acid analog based on morpholino-modified phosphorodiamidate oligomers (PMO) antisense chemistry
Molecular Target
Mechanism of Action 
Therapeutic ModalityNucleic acid: Linear RNA: Antisense
Latest Stage of DevelopmentPhase I
Standard IndicationViral infection
Indication DetailsTreat Marburg virus infection
Regulatory Designation U.S. - Fast Track (Treat Marburg virus infection)

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today